TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
CombiGene AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
500
|
2,399
|
8,218 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-3,214
|
-553
|
2,050 |
EBITDA |
-3,242
|
-391
|
2,304 |
Total assets |
10,870
|
14,218
|
16,253 |
Current assets |
9,304
|
12,510
|
14,141 |
Current liabilities |
374
|
548
|
777 |
Equity capital |
10,495
|
13,670
|
15,477 |
- share capital |
89
![]() |
89
|
97 |
Employees (average) |
8
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.6%
|
96.1%
|
95.2% |
Turnover per employee |
62
|
240
|
1,027 |
Profit as a percentage of turnover |
-642.8%
|
-23.1%
|
24.9% |
Return on assets (ROA) |
-29.6%
|
-3.9%
|
12.6% |
Current ratio |
2487.7%
|
2282.8%
|
1819.9% |
Return on equity (ROE) |
-30.6%
|
-4.0%
|
13.2% |
Change turnover |
-1,907
|
-5,153
|
8,218 |
Change turnover % |
-79%
|
-68% | |
Chg. No. of employees |
-2
|
2
|
4 |
Chg. No. of employees % |
-20%
|
25%
|
100% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.